Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.074 EUR
−2.67 B EUR
48.70 B EUR
3.93 B
About Bayer AG
Sector
Industry
CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
IPO date
Nov 28, 1997
Identifiers
3
ISIN US0727303028
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BAYZ4140706
Monsanto Company 4.7% 15-JUL-2064Yield to maturity
7.19%
Maturity date
Jul 15, 2064
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042Yield to maturity
6.94%
Maturity date
Jul 15, 2042
BAYZ4230946
Monsanto Company 3.95% 15-APR-2045Yield to maturity
6.75%
Maturity date
Apr 15, 2045
BAYZ4067527
Monsanto Company 4.65% 15-NOV-2043Yield to maturity
6.74%
Maturity date
Nov 15, 2043
BAYZ4140707
Monsanto Company 4.4% 15-JUL-2044Yield to maturity
6.52%
Maturity date
Jul 15, 2044
US7274NBH5
Bayer US Finance II LLC 4.7% 15-JUL-2064Yield to maturity
6.42%
Maturity date
Jul 15, 2064
B16A
Bayer US Finance II LLC 4.7% 15-JUL-2064Yield to maturity
6.35%
Maturity date
Jul 15, 2064
US7274NBG7
Bayer US Finance II LLC 3.95% 15-APR-2045Yield to maturity
6.23%
Maturity date
Apr 15, 2045
US7274EAM5
Bayer US Finance LLC 6.875% 21-NOV-2053Yield to maturity
6.22%
Maturity date
Nov 21, 2053
US7274NBF9
Bayer US Finance II LLC 4.4% 15-JUL-2044Yield to maturity
6.17%
Maturity date
Jul 15, 2044
USU07265AH1
Bayer US Finance II LLC 4.875% 25-JUN-2048Yield to maturity
6.17%
Maturity date
Jun 25, 2048
See all BAYA bonds
